482
Views
26
CrossRef citations to date
0
Altmetric
Review

Considerations for managing chronic obstructive pulmonary disease in the elderly

, &
Pages 23-30 | Published online: 13 Dec 2013

References

  • AkinbamiLJLiuXChronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998–2009NCHS Data Brief2011631822142836
  • Centers for Disease Control and Prevention, National Center for Health StatisticsData brief 63: chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998–2009 Available from: http://www.cdc.gov/nchs/data/databriefs/db63_tables.pdf#2Accessed August 8, 2013
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease2013 Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.htmlAccessed August 30, 2013
  • BourbeauJBartlettSJPatient adherence in COPDThorax200863983183818728206
  • JanssensJPAging of the respiratory system: impact on pulmonary function tests and adaptation to exertionClin Chest Med2005263469vii16140139
  • SharmaGGoodwinJEffect of aging on respiratory system physiology and immunologyClin Interv Aging20061325326018046878
  • HankinsonJLOdencrantzJRFedanKBSpirometric reference values from a sample of the general US populationAm J Respir Crit Care Med199915911791879872837
  • PezzoliLGiardiniGConsonniSQuality of spirometric performance in older peopleAge Ageing2003321434612540347
  • AllenSCBaxterMA comparison of four tests of cognition as predictors of inability to perform spirometry in old ageAge Ageing200938553754119553358
  • TombaughTNMcIntyreNJThe Mini-Mental State Examination: a comprehensive reviewJ Am Geriatr Soc19924099229351512391
  • QaseemAWiltTJWeinbergerSEDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnn Intern Med2011155317919121810710
  • BrocklebankDRamFWrightJComparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literatureHealth Technol Assess2001526114911701099
  • BarronsRPegramABorriesAInhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary diseaseAm J Health Syst Pharm201168131221123221690428
  • ZarowitzBJO’SheaTChronic obstructive pulmonary disease: prevalence, characteristics, and pharmacologic treatment in nursing home residents with cognitive impairmentJ Managed Care Pharm2012188598606
  • RestrepoRDAlvarezMTWittnebelLDMedication adherence issues in patients treated for COPDInt J Chron Obstruct Pulmon Dis20083337138418990964
  • GeorgeJKongDCThomanRStewartKFactors associated with medication nonadherence in patients with COPDChest200512853198320416304262
  • Centers for Disease Control and PreventionAnnual smoking-attributable mortality, years of potential life lost, and productivity losses – United States, 1997–2001MMWR Morb Mortal Wkly Rep2005542562562815988406
  • GentilLVasiliadisHMPrevilleMBosseCBerbicheDAssociation between depressive and anxiety disorders and adherence to antihypertensive medication in community-living elderly adultsJ Am Geriatr Soc201260122297230123110563
  • BosleyCMCordenZMReesPJCochraneGMPsychological factors associated with use of home nebulized therapy for COPDEur Respir J1996911234623508947083
  • AllenSCCompetence thresholds for the use of inhalers in people with dementiaAge Ageing199726283869177663
  • DoddJWGetovSVJonesPWCognitive function in COPDEur Respir J201035491392220356988
  • VilleneuveSPepinVRahayelSMild cognitive impairment in moderate to severe COPD: a preliminary studyChest201214261516152323364388
  • GraySLWilliamsDMPulliamCCSirgoMABishopALDonohueJFCharacteristics predicting incorrect metered-dose inhaler technique in older subjectsArch Intern Med199615699849888624178
  • BarrRGCelliBRManninoDMComorbidities, patient knowledge, and disease management in a national sample of patients with COPDAm J Med2009122434835519332230
  • BrennanVKOsmanLMGrahamHCritchlowAEverardMLTrue device compliance: the need to consider both competence and contrivanceRespir Med20059919710215672856
  • GiraudVRocheNMisuse of corticosteroid metered-dose inhaler is associated with decreased asthma stabilityEur Respir J200219224625111866004
  • WieshammerSDreyhauptJDry powder inhalers: which factors determine the frequency of handling errors?Respiration2008751182517911976
  • ChapmanKRVoshaarTHVirchowJCInhaler choice in primary practiceEur Respir Rev20051496117122
  • HessDRMetered-dose inhalers and dry powder inhalers in aerosol therapyRespir Care200550101376138316185372
  • ToddMABaskettJJRichmondDEInhaler devices and the elderlyN Z Med J199010388343462304689
  • YawnBPColiceGLHodderRPractical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care settingInt J Chron Obstruct Pulmon Dis201274957502
  • GraySLNanceACWilliamsDMPulliamCCAssessment of interrater and intrarater reliability in the evaluation of metered dose inhaler techniqueChest199410537107148131530
  • AtkinsPJDry powder inhalers: an overviewRespir Care200550101304131216185366
  • LavoriniFMagnanADubusJCEffect of incorrect use of dry powder inhalers on management of patients with asthma and COPDRespir Med2008102459360418083019
  • BroedersMEVinckenWCorbettaLThe ADMIT series – Issues in Inhalation Therapy. 7. Ways to improve pharmacological management of COPD: the importance of inhaler choice and inhalation techniquePrim Care Respir J201120333834321808941
  • JanssensWVandenBrandePHardemanEInspiratory flow rates at different levels of resistance in elderly COPD patientsEur Respir J2008311788317898020
  • Al-ShowairRATarsinWYAssiKHPearsonSBChrystynHCan all patients with COPD use the correct inhalation flow with all inhalers and does training help?Respir Med2007101112395240117629471
  • MahlerDAWatermanLAGiffordAHPrevalence and COPD pheno-type for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus(®) dry powder inhalerJ Aerosol Med Pulm Drug Deliv201326317417923025451
  • FilukRDelivery system selection: clinical considerationsAm Health Drug Benefits20081Suppl 81317
  • RauJLPractical problems with aerosol therapy in COPDRespir Care200651215817216441960
  • DolovichMBDhandRAerosol drug delivery: developments in device design and clinical useLancet201137797701032104521036392
  • BowlesSKSketrisIKephartGUse of wet nebulized inhaled respiratory medications under criteria-based reimbursement guidelines in a publicly funded Seniors’ Pharmacare Program in Nova Scotia, CanadaAm J Geriatr Pharmacother20075212012817719514
  • ReesJABC of asthma. Methods of delivering drugsBMJ2005331751550450616141159
  • DolovichMBAhrensRCHessDRDevice selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and ImmunologyChest2005127133537115654001